How Much Is Enough? The Continuing Debate on the Axillary Lymph Node Dissection in Breast Cancer

How Much Is Enough? The Continuing Debate on the Axillary Lymph Node Dissection in Breast Cancer
Veronica C Shim, MD, FACS

 

Spring 2007 - Volume 11 Number 2

https://doi.org/10.7812/TPP/06-085

Since the Halsted radical mastectomy was introduced in 1894,1 breast cancer treatment has undergone major changes. More than a century later, breast conserving surgery is now accepted in the treatment armamentarium of early breast cancer. However, the role of axillary lymph node dissection (ALND) in breast cancer treatment continues to be controversial. The persistent question in this debate is whether we should abandon axillary lymph node evaluation in breast cancer management; I believe we cannot.

 

Click here to join the ETOC list or text ETOC to 22828. You will receive an email notice with the Table of Contents of each issue.

Circulation

27,000 print readers per quarter, 11,225 eTOC readers, and in 2017, 1.5 million page views of TPJ articles in PubMed from a broad international readership.

The Permanente Journal

The Permanente Journal advances knowledge in scientific research, clinical medicine, and innovative health care delivery.

Reprint Permissions

The Permanente Journal welcomes requests for reprints and reproduction. Use of any and all material published in The Permanente Journal is copyrighted and protected.


ISSN 1552-5775 Copyright © 2018 thepermanentejournal.org.

The Permanente Press. All Rights Reserved.